Monotherapy With Metformin Versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis

Journal of Diabetes Research - Egypt
doi 10.1155/2019/7676909
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Metformin Use Improves Survival of Diabetic Liver Cancer Patients: Systematic Review and Meta-Analysis

Oncotarget
Oncology
2016English

Survival Benefits of Metformin for Colorectal Cancer Patients With Diabetes: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Efficacy and Safety of Metronidazole Monotherapy Versus Vancomycin Monotherapy or Combination Therapy in Patients With Clostridium Difficile Infection: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Risk of Pre-Eclampsia in Women Taking Metformin: A Systematic Review and Meta-Analysis

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Risk of Colorectal Cancer in Asian Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2017English

Effect of Metformin Use on the Risk and Prognosis of Endometrial Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Metformin Use and Survival Outcomes in Endometrial Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Alpha-Glucosidase Inhibitors and Risk of Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Quetiapine Monotherapy Versus Placebo in the Treatment of Children and Adolescents With Bipolar Depression: A Systematic Review and Meta-Analysis

Neuropsychiatric Disease and Treatment
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy